New jobs coming to Smyth Co. as transformer manufacturer expands
SMYTH COUNTY, Va. (WJHL) — A company that makes electrical grid infrastructure is adding a warehouse in Smyth County, Virginia and expanding its facility in Bland County – a move that will create 120 new jobs.
Virginia Governor Glenn Youngkin's office announced in a news release Friday that Hitachi Energy is expanding operations to meet increased demand. Hitachi Energy is growing its transformer production capacity in the Commonwealth by investing $22.5 million.
Open house held as Tri-Cities Airport Master Plan nears completion
The investment will expand the company's facility in Bland and add a warehouse in Atkins. The Atkins site 'will handle core cutting and warehousing work,' according to the release.
'Hitachi Energy's investment in the new Atkins facility and the transformative modernization of the Bland plant is a powerful endorsement of Virginia's manufacturing capabilities. This world-class company's investment in Southwest Virginia is not only expanding domestic transformer production, but also creating high-quality, skilled jobs and driving innovation in energy infrastructure. Hitachi Energy is a trusted, long-term partner with Virginia, and together we are growing a hub of energy innovation and infrastructure advancement.'
Governor Glenn Youngkin
Steve McKinney, Hitachi Energy's senior vice president and head of transformers in North America, said Virginia has been pivotal in the company's success for decades.
'The new facility in Atkins, alongside the upgrades at our existing site in Bland, represents a major milestone in our commitment to building resilient energy infrastructure in the U.S.,' McKinney said.
About 450 people are employed at the current Bland facility, which has been in operation since 1972. The Bland location manufactures transformers used across the United States.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Strongwell products to be distributed throughout Europe
BRISTOL, Va. (WJHL) — Strongwell, headquartered in Bristol, Virginia, announced on Thursday it has entered an agreement with Module Solutions & Systems AS (MSS) of Norway. The agreement allows MSS to distribute Strongwell's products in Europe, excluding the United Kingdom, according to a news release posted by the City of Bristol, Virginia. 'We are excited to have MSS as our European distribution partner,' Strongwell Vice President of Sales and Engineering David Gibbs said in the release. 'Their experience and presence in the region will allow us to better serve international customers with Strongwell's high-performance, American-made composite products.' Crews to start building baseball field elements inside Bristol Motor Speedway MSS will distribute standard and non-standard FRP products from Strongwell. 'This agreement with Strongwell marks an exciting new chapter for MSS,' MSS Managing Director Morten Alstadsæther said in the release. 'Strongwell's FRP solutions are world-class, and we are proud to offer European customers local access to these proven, high-performance products. Our team is fully committed to supporting clients with technical expertise and responsive service, ensuring the success of every project we're part of.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ('Treace' or the 'Company') (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, 'Zimmer') (NYSE: ZBH), alleging infringement of 4 patents related to Treace's innovative Lapiplasty® 3D Bunion Correction® technologies. The suit was filed in the United States District Court for the District of Delaware, and seeks injunctive relief and damages. 'Treace Medical was the first company to develop, patent, and introduce an instrumented 3D bunion correction system for true tri-planar lapidus bunion correction and is the recognized leader in the surgical treatment of bunions. We believe that this lawsuit is necessary to protect the significant investments we have made in our pioneering research and technology, which is in the best interest of our stockholders,' said John T. Treace, Chairman, CEO and Founder of Treace. 'Enforcing and defending our intellectual property helps to drive our ability to continue to innovate solutions that benefit patients.' Treace's patent portfolio includes 80 granted U.S. patents, with an additional 26 granted patents worldwide and over 150 pending patent applications. About Treace Medical Concepts Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of bunion patients, Treace has introduced its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP™ Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty™ 3D Minimally Invasive Bunion Correction System and the Percuplasty™ Percutaneous 3D Bunion Correction System. The Company continues to expand its footprint in the foot and ankle market with the introduction of its SpeedPlate™ Rapid Compression Implants, an innovative fixation platform with broad versatility across Lapiplasty® and Adductoplasty® procedures, as well as other common bone fusion procedures of the foot. For more information, please visit To learn more about Treace, connect with us on LinkedIn, X, Facebook and Instagram. Contacts:Treace Medical ConceptsMark L. HairChief Financial Officermhair@ 373-5940 Investors:Gilmartin GroupPhilip Trip Taylor IR@
Miami Herald
an hour ago
- Miami Herald
GPOPlus+ Announces the Launch of Call Center Operations to Expand Direct B2B Sales
The new sales channel enhances nationwide reach and scalesrevenue, complementing its direct store delivery (DSD) distribution initialrevenuepotential of 10 seats is estimated to generate $50,000 to $100,000 per seat per month, totalling $500, up to 22 seats, generating $50,000 per month per seat, representing additional revenue of $1,100,000 monthly, or $13,200,000 annually. LAS VEGAS, NV / ACCESS Newswire / June 5, 2025 / GPO Plus, Inc.(OTCQB:GPOX), an AI-powered Distributor revolutionizing distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model, today announced the launch of its new in-house call center operation based in Las Vegas, Nevada. This expansion marks a key milestone in GPOX's growth strategy, significantly broadening its ability to reach new retail customers and increase revenue across additional sales channels. The newly operational call center represents a highly scalable and cost-effective way to drive B2B sales to independent retailers, including smoke shops, vape shops, liquor stores, small grocers, and convenience stores that fall outside the traditional DSD footprint. This initiative works in tandem with the company's field teams, DISTRO+ Wholesale Portal, and regional hubs, forming a comprehensive multi-channel distribution strategy designed to accelerate nationwide growth. The team is starting with a well-curated lead database of over 70,000 retail accounts, focusing on selling GPOX's proven product lines, including its high-margin private-label SKUs. As previously announced, industry benchmarks indicate that $50,000-$100,000 in monthly sales can be achieved per seat. With operations now live, the call center is well-positioned to make meaningful contributions to top-line growth and drive additional market penetration, eliminating the need for physical delivery infrastructure. GPOX has hired an industry veteran and seasoned sales operations leader with extensive experience in call centers to lead the new team. The initial rollout includes up to 10 seats, with the infrastructure and lead volume in place to expand to 22 seats. The projected monthly revenue goal of $50,000 to $100,000 per seat, or $1.1 million to $2.2 million per month (expansion to 22 seats), and the corresponding annualized estimate of $13.2 million to $26.4 million are based on industry averages. "This is a high-impact revenue growth lever for GPOX that has moved quickly from concept to execution," said Brett H. Pojunis, CEO of GPOX. "We expect to have the first 10 seats filled by the end of July, and the expansion up to 22 seats by the end of fiscal Q2 (August to October, 2025). We've streamlined our operations, increased our margins, and now we're aggressively expanding. The call center allows us to rapidly scale into new geographies, deepen our retail penetration, and drive direct B2B sales. Our new manager brings exactly the leadership we need to maximize this opportunity." This initiative complements other recent activations, including the launch of the DISTRO+ Wholesale Portal, the opening of new ambient-temperature-controlled warehouses in Las Vegas and Lubbock, and the deployment of GPOX field teams to expand regional account penetration. For more information on GPOX's growth initiatives, visit Connect with us on social media to view live video updates, content, and general information about GPOX: About GPOPlus+ (GPOX)GPOX is an AI-powered Distributor revolutionizing the future of distribution to gas stations and convenience stores with its innovative technology-driven Direct Store Delivery (DSD) model. Our goal is clear and ambitious: "to build the largest nationwide DSD distribution company servicing gas stations, convenience stores, and beyond." Our technology-driven AI network, featuring strategically placed Regional Hubs and Mini Hubs, is designed to optimize efficiency and maximize reach. Central to our operations is our in-house AI technology platform, PRISM+. Designed to streamline the distribution process, PRISM+ supports efficient delivery, inventory management, data analytics, and overall operational excellence, enabling us to reliably and effectively meet the dynamic needs of our partners. Our mission is to consolidate the fragmented market segment managed by numerous regional vendors. Our dedication to excellence is evident in our product selection process, where we align offerings with consumer demand and partner with top-tier vendors and brands, ensuring our portfolio remains diverse and highly profitable. For more information, please visit Information about Forward-Looking StatementsThis press release contains "forward-looking statements" that include statements regarding expected financial performance and growth information relating to future events. Forward-looking statements include statements with respect to beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond the control of the Company and its officers and managers, and which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to; inability to gain or maintain licenses, reliance on unaudited statements, the Company's need for additional funding, governmental regulation of the cannabis industry, the impact of competitive products and pricing, the demand for the Company's products, and other risks that are detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. All statements other than statements of historical fact are statements that could be forward-looking statements. You can typically identify these forward-looking statements through use of words such as "may," "will," "can" "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "seek," "estimate," "continue," "plan," "point to," "project," "predict," "could," "intend," "target," "potential," and other similar words and expressions of the future. The Company expresses its expectations, beliefs and projections in good faith and believes that its expectations reflected in these forward-looking statements are based on reasonable assumptions. However, there is no assurance that these expectations, beliefs and projections will prove to have been correct. Such statements reflect the current views of the Company with respect to its operations and future events, and are subject to certain risks, uncertainties and assumptions relating to its proposed operations, including the risk factors set forth herein. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, the Company's actual results may vary significantly from those intended, anticipated, believed, estimated, expected or planned. In light of these risks, uncertainties and assumptions, any favorable forward-looking events discussed herein might not be realized and occur. The Company has no obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. For a more detailed description of the risk factors and uncertainties affecting GPO Plus, Inc. GPOX, please refer to the Company's recent Securities and Exchange Commission filings, which are available at The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Company Contacts:GPOX Shareholder Success Team:Brett H. Pojunis, CEOEmail: ir@ Line: (4769) ### SOURCE: GPO Plus, Inc.
